#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
David Eveleth Email
CEO . Trefoil Therapeutics
San Diego, CA
Locationd*******@trefoiltherapeutics.com
Primary EmailHow to contact David Eveleth
Join and see David's contact info for free!Current Roles
Employees:
21Revenue:
$3.3MAbout
Trefoil is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop first-in-class regenerative pharmacologic treatments for corneal diseases, which are debilitating and cause a significant amount of preventable blindness throughout the world. Lead candidate TTHX1114 is an engineered form of FGF-1 designed to stimulate proliferation and migration of corneal endothelial cells. It is initially being developed as an intracameral injection as the first pharmacologic treatment for back of the cornea surface disease (endothelial dystrophy), the leading cause of cornea transplantation surgeries. Trefoil's second development program focuses on a topical eye drop formulation of TTHX1114 for the treatment of ulcerative conditions on the front surface of the cornea which leads to corneal scarring and substantial loss of vision.Trefoil Therapeutics Address
6330 Nancy Ridge DriveSan Diego, CA
United States